Published in J Med Vet Mycol on January 01, 1989
Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans. Clin Microbiol Rev (1995) 8.81
Hybridization probes for conventional DNA fingerprinting used as single primers in the polymerase chain reaction to distinguish strains of Cryptococcus neoformans. J Clin Microbiol (1993) 2.78
Monoclonal antibodies to Cryptococcus neoformans capsular polysaccharide modify the course of intravenous infection in mice. Infect Immun (1994) 2.07
Antibody-mediated protection in mice with lethal intracerebral Cryptococcus neoformans infection. Proc Natl Acad Sci U S A (1993) 1.86
Pathogenesis of pulmonary Cryptococcus neoformans infection in the rat. Infect Immun (1994) 1.83
Killing of Cryptococcus neoformans strains by human neutrophils and monocytes. Infect Immun (1991) 1.80
Human natural killer cells do not inhibit growth of Cryptococcus neoformans in the absence of antibody. Infect Immun (1990) 1.70
Role of phagocytosis in the virulence of Cryptococcus neoformans. Eukaryot Cell (2004) 1.57
Cryptococcal interactions with the host immune system. Eukaryot Cell (2010) 1.57
Encapsulation of Cryptococcus neoformans impairs antigen-specific T-cell responses. Infect Immun (1991) 1.54
Encapsulation of Cryptococcus neoformans regulates fungicidal activity and the antigen presentation process in human alveolar macrophages. Clin Exp Immunol (1994) 1.37
Cryptococcus neoformans {alpha} strains preferentially disseminate to the central nervous system during coinfection. Infect Immun (2005) 1.33
Strain variation in antiphagocytic activity of capsular polysaccharides from Cryptococcus neoformans serotype A. Infect Immun (1989) 1.22
In vivo role of dendritic cells in a murine model of pulmonary cryptococcosis. Infect Immun (2006) 1.21
A 77-kilodalton protein of Cryptococcus neoformans, a member of the heat shock protein 70 family, is a major antigen detected in the sera of mice with pulmonary cryptococcosis. Infect Immun (1997) 1.14
Surfactant protein D increases phagocytosis of hypocapsular Cryptococcus neoformans by murine macrophages and enhances fungal survival. Infect Immun (2009) 1.04
Automated analysis of cryptococcal macrophage parasitism using GFP-tagged cryptococci. PLoS One (2010) 0.97
Identification of N-acetylneuraminic acid and its 9-O-acetylated derivative on the cell surface of Cryptococcus neoformans: influence on fungal phagocytosis. Infect Immun (1997) 0.90
Capsules from pathogenic and non-pathogenic Cryptococcus spp. manifest significant differences in structure and ability to protect against phagocytic cells. PLoS One (2012) 0.90
Concurrent presentation of cryptococcal meningoencephalitis and systemic lupus erythematosus. Mod Rheumatol (2010) 0.86
Histone deacetylases inhibitors effects on Cryptococcus neoformans major virulence phenotypes. Virulence (2015) 0.78
Differential activation of peritoneal cells by subcutaneous treatment of rats with cryptococcal antigens. Clin Vaccine Immunol (2009) 0.75
Molecular markers reveal that population structure of the human pathogen Candida albicans exhibits both clonality and recombination. Proc Natl Acad Sci U S A (1996) 3.53
In vitro phagocytosis and intracellular fate of variously encapsulated strains of Cryptococcus neoformans. Infect Immun (1972) 3.05
Hybridization probes for conventional DNA fingerprinting used as single primers in the polymerase chain reaction to distinguish strains of Cryptococcus neoformans. J Clin Microbiol (1993) 2.78
Multiple gene genealogies reveal recent dispersion and hybridization in the human pathogenic fungus Cryptococcus neoformans. Mol Ecol (2000) 2.30
Killing of Cryptococcus neoformans strains by human neutrophils and monocytes. Infect Immun (1991) 1.80
Water and sodium absorption in the human intestine. J Physiol (1968) 1.72
Human natural killer cells do not inhibit growth of Cryptococcus neoformans in the absence of antibody. Infect Immun (1990) 1.70
Identification of clinical strains of Candida albicans by DNA fingerprinting with the polymerase chain reaction. Mycoses (1994) 1.67
PCR-restriction fragment length polymorphism (RFLP) analyses reveal both extensive clonality and local genetic differences in Candida albicans. Mol Ecol (1999) 1.60
Genetic structure of typical and atypical populations of Candida albicans from Africa. Fungal Genet Biol (1999) 1.59
Rapid identification of Candida species by DNA fingerprinting with PCR. J Clin Microbiol (1996) 1.52
Clonal and spontaneous origins of fluconazole resistance in Candida albicans. J Clin Microbiol (2000) 1.50
Strain variation and morphogenesis of yeast- and mycelial-phase Candida albicans in low-sulfate, synthetic medium. J Bacteriol (1980) 1.41
Analysis of cytoplasmic antigens of the yeast and mycelial phases of Candida albicans by two-dimensional electrophoresis. Infect Immun (1980) 1.28
The taxonomy, differentiation and identification of Cytophaga species. J Appl Bacteriol (1969) 1.26
Species and genotypic diversities and similarities of pathogenic yeasts colonizing women. J Clin Microbiol (1999) 1.26
Polymerase chain reaction fingerprinting in fungi using single primers specific to minisatellites and simple repetitive DNA sequences: strain variation in Cryptococcus neoformans. Electrophoresis (1995) 1.22
Strain variation in antiphagocytic activity of capsular polysaccharides from Cryptococcus neoformans serotype A. Infect Immun (1989) 1.22
Binding of purified and radioiodinated capsular polysaccharides from Cryptococcus neoformans serotype A strains to capsule-free mutants. Infect Immun (1986) 1.20
Morphogenesis of Candida albicans and cytoplasmic proteins associated with differences in morphology, strain, or temperature. J Bacteriol (1980) 1.18
Identification of pathogenic yeasts of the imperfect genus Candida by polymerase chain reaction fingerprinting. Electrophoresis (1997) 1.17
Analysis of genes coding for small-subunit rRNA sequences in studying phylogenetics of dematiaceous fungal pathogens. J Clin Microbiol (1995) 1.16
Strain variation in composition and molecular size of the capsular polysaccharide of Cryptococcus neoformans serotype A. Infect Immun (1986) 1.16
Lack of genetic differentiation between two geographically diverse samples of Candida albicans isolated from patients infected with human immunodeficiency virus. J Bacteriol (1999) 1.14
Killing of Cryptococcus neoformans by rat alveolar macrophages. J Med Vet Mycol (1989) 1.14
Comparison of an enzyme-linked immunoassay and a quantitative indirect fluorescent-antibody test with the conventional indirect fluorescent-antibody test for detecting antibodies to Toxoplasma gondii. J Clin Microbiol (1982) 1.14
Comparison of use of phenotypic and genotypic characteristics for identification of species of the anamorph genus Candida and related teleomorph yeast species. J Clin Microbiol (1997) 1.12
Assessment of genetic relatedness of vaginal isolates of Candida albicans from different geographical origins. Int J Med Microbiol (2000) 1.08
DNA- and PCR-fingerprinting in fungi. EXS (1993) 1.06
Uniparental mitochondrial transmission in sexual crosses in Cryptococcus neoformans. Curr Microbiol (2000) 1.06
Phagocytosis and killing of Cryptococcus neoformans by rat alveolar macrophages in the absence of serum. J Leukoc Biol (1989) 1.06
Cathartics and the sodium pump. Nature (1965) 1.05
Immunoblot analyses of Candida albicans-associated antigens and antibodies in human sera. J Clin Microbiol (1986) 1.04
Development and characterization of a genetic linkage map of Cryptococcus neoformans var. neoformans using amplified fragment length polymorphisms and other markers. Fungal Genet Biol (2000) 0.99
Isolation of Cryptococcus gattii and Cryptococcus neoformans var. grubii from the flowers and bark of Eucalyptus trees in India. Med Mycol (2005) 0.94
Adjunctive hyperbaric oxygen for treatment of rhinocerebral mucormycosis. Rev Infect Dis (1988) 0.91
Dynamic and heterogeneous mutations to fluconazole resistance in Cryptococcus neoformans. Antimicrob Agents Chemother (2001) 0.91
Pathogenesis of Cryptococcus neoformans is associated with quantitative differences in multiple virulence factors. Mycopathologia (1999) 0.90
Colony size can be used to determine the MIC of fluconazole for pathogenic yeasts. J Clin Microbiol (1998) 0.89
Blastomyces dermatitidis chemotactic factor: kinetics of production and biological characterization evaluated by a modified neutrophil chemotaxis assay. Infect Immun (1984) 0.87
[Genetic structure of geographically different populations of candida albicans]. Mycoses (2000) 0.86
Molecular typing of pathogenic fungi. Med Mycol (2000) 0.86
Evaluation of a digital microfluidic real-time PCR platform to detect DNA of Candida albicans in blood. Eur J Clin Microbiol Infect Dis (2012) 0.84
Induction of interleukin-6 mRNA in rat alveolar macrophages by in vitro exposure to both Cryptococcus neoformans and anti-C. neoformans antiserum. J Med Vet Mycol (1998) 0.83
Effects of culture filtrates of Blastomyces dermatitidis on neutrophil locomotion. Sabouraudia (1984) 0.80
Urinary cobalt levels in patients with porous Austin-Moore prostheses. Clin Orthop Relat Res (1983) 0.78
Opening the doors: family presence during resuscitation. J Cardiovasc Nurs (1996) 0.78
Human platelets labeled with In-111 8-hydroxyquinoline: kinetics, distribution, and estimates of radiation dose. J Nucl Med (1982) 0.77
Transport of sodium and water by rabbit ileum, in vitro and in vivo. Nature (1965) 0.77
Recovery from disseminated candidiasis in a premature neonate. Pediatrics (1974) 0.75
Instrumentation. Environ Health Ser Radiol Health (1967) 0.75
Radionuclide dosimetry. Radiol Clin North Am (1969) 0.75
Evaluation of a cytocentrifuge method for measuring neutrophil granulocyte chemotaxis. J Lab Clin Med (1975) 0.75
[Global and sectorized estimation of ocular blood flow in dogs by labelled microsphere method: relation to intraocular pressure]. Bull Mem Soc Fr Ophtalmol (1973) 0.75
Elementary radiation dosimetry. J Nucl Med (1967) 0.75
Thyroid ablation in young mice--a technique combining surgery and iodine-131. Int J Appl Radiat Isot (1971) 0.75
A simple method to measure mesenteric arteriovenous shunt flow during arteriography. Invest Radiol (1979) 0.75
Comparison of glycoproteins isolated by phenol-water partition of human erythrocyte membranes. Immunol Commun (1973) 0.75